IMCC
IM Cannabis Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$4.23
+143.10%Next report
Analyst consensus
- Next report date
- Nov 16, 2026
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.34
- EPS estimate
- —
- Revenue actual
- $5.5M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -790.7%
- Revenue beats (12Q)
- 1
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | — | -$0.34 | — | $5.5M |
| May 13, 2026 | — | -$0.28 | — | $4.5M |
| Mar 30, 2026 | $0.09 | -$0.86 | Miss -1100.47% | $11.4M |
| Nov 13, 2025 | -$0.02 | -$0.54 | Miss -2234.63% | $9.9M |
| Aug 12, 2025 | -$0.14 | -$0.07 | Beat 48.79% | $9.3M |
| May 15, 2025 | -$0.25 | $0.06 | Beat 123.56% | $8.8M |
| Mar 31, 2025 | -$0.39 | -$0.23 | Beat 41.03% | $9.3M |
| Nov 14, 2024 | -$0.70 | -$0.30 | Beat 57.14% | $10.2M |
| Aug 14, 2024 | -$0.84 | -$0.17 | Beat 79.76% | $10.8M |
| Aug 14, 2023 | -$0.78 | -$1.14 | Miss -46.15% | $10.0M |
| May 15, 2023 | -$1.20 | $0.12 | Beat 110.00% | $9.7M |
| Nov 14, 2022 | -$3.60 | -$3.00 | Beat 16.67% | $10.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 16, 2026